Patents by Inventor Ulrike D. Sent

Ulrike D. Sent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10357479
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: July 23, 2019
    Assignee: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Publication number: 20180193317
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Application
    Filed: March 8, 2018
    Publication date: July 12, 2018
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Patent number: 9949954
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: April 24, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Publication number: 20170128423
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Application
    Filed: January 20, 2017
    Publication date: May 11, 2017
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Patent number: 9585873
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Grant
    Filed: June 2, 2014
    Date of Patent: March 7, 2017
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Patent number: 9308197
    Abstract: A pharmaceutical composition for prophylaxis or treatment of systemic diseases in cats, wherein the composition comprising administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to a cat in need of such a treatment.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: April 12, 2016
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Marcus Stark, Ulrike D Sent, Ingo Lang
  • Publication number: 20140288138
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Application
    Filed: June 2, 2014
    Publication date: September 25, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang